Confidential STI Tests, Home Sample Collection & Doctor-Guided Treatment
STD testing identifies sexually transmitted infections using the right laboratory method, specimen site and timing—even when no symptoms are present. STDtest.clinic provides a clinician-led pathway for sexual-health concerns, from risk assessment and appropriate testing to result interpretation, prescriptions and eligible treatment at home or in a hotel. Our primary service base is Arjan, Dubai; mobile care across Dubai and selected Abu Dhabi, Sharjah and other UAE locations depends on confirmed coverage, professional licensing, clinical suitability and the required medicine or equipment.
Book STD Testing | Arrange a Home or Hotel Visit | Speak to a Doctor | Urgent HIV PEP Assessment
The right test is not always the largest panel. Someone with genital discharge may need chlamydia and gonorrhea NAATs; a person with oral exposure may need a throat swab; a person with a genital ulcer may need lesion-based HSV testing and syphilis serology. A recent potential HIV exposure within 72 hours needs urgent PEP assessment rather than waiting for a routine test result.
STD testing selected around your exposure, symptoms and timing
Sexually transmitted infections may cause no noticeable symptoms. Chlamydia, gonorrhea, syphilis, HIV and several other infections can remain undetected until screening, a partner notification or a complication prompts assessment. The absence of pain, discharge, sores or fever does not establish that a person is infection-free.
Testing is appropriate when there is a reason to evaluate a possible infection or screen for risk. Common reasons include sex without a condom, condom breakage, a new partner, a partner’s positive test, symptoms, a pregnancy-related screening requirement or follow-up after treatment. Screening frequency should reflect personal risk, pregnancy status, exposure sites, vaccination history and previous diagnoses—not a universal schedule imposed on everyone.
A condom reduces but does not eliminate every STI risk. Correct condom use reduces exposure to many infections transmitted through genital fluids; infections transmitted by skin-to-skin contact, including HPV, herpes and syphilis lesions outside covered areas, can still occur. Oral sex can transmit gonorrhea, syphilis, herpes and other infections, even when there is no penetration.
Symptoms require a differential diagnosis rather than an assumed STD. Burning urination can be caused by urethritis or a urinary tract infection; vaginal discharge may reflect bacterial vaginosis or candidiasis rather than an STI; genital itching can have dermatological causes. Examination and targeted tests help avoid unnecessary antibiotics.
STD tests and the specimens they require
| Infection or concern | Common diagnostic approach | Important limitation |
| Chlamydia (*Chlamydia trachomatis*) | NAAT on first-catch urine or appropriate vaginal, cervical, rectal or throat swab | Urine does not exclude rectal or throat infection |
| Gonorrhea (*Neisseria gonorrhoeae*) | Site-specific NAAT; culture when resistance or treatment failure is suspected | Pharyngeal infection is often symptom-free |
| Syphilis (*Treponema pallidum*) | Treponemal plus quantitative nontreponemal blood tests | Very early disease may test negative; previous infection affects interpretation |
| HIV-1/2 | Laboratory antigen/antibody test; HIV RNA/NAT in selected cases | Window periods and antiretroviral use affect interpretation |
| Hepatitis B | HBsAg, anti-HBs and anti-HBc as indicated | Tests distinguish infection, immunity and prior exposure |
| Hepatitis C | HCV antibody with HCV RNA confirmation of current infection | Positive antibody alone does not prove current infection |
| Genital herpes (HSV-1/2) | PCR/NAAT swab from a fresh lesion | A negative healing-lesion swab does not fully exclude HSV |
| Trichomoniasis (*T. vaginalis*) | Targeted NAAT | Not necessarily included in a routine chlamydia/gonorrhea panel |
| *Mycoplasma genitalium* | Targeted NAAT in selected persistent/recurrent cases | Not recommended as universal asymptomatic screening |
| HPV and genital warts | Clinical examination; cervical HPV screening where indicated | No general-purpose blood test for genital HPV |
Urine collection and urine culture answer different questions. First-catch urine is commonly used for genital chlamydia/gonorrhea NAAT; a midstream urine culture investigates typical urinary pathogens. Patients should follow the laboratory’s specific collection instructions rather than assume any urine specimen works for both.
Throat and rectal swabs matter when those sites were exposed. A negative genital sample does not rule out infection elsewhere. Sample selection should be anatomically relevant and based on informed discussion, without assumptions about a patient’s identity or relationship.
A lesion swab can be more useful than a routine blood panel for a new blister or ulcer. Early HSV lesions can be sampled by PCR/NAAT; syphilis evaluation may require serology and additional assessment. Do not wait until a sore has completely healed if testing is needed.
STD testing after sex: when results become meaningful
There is no single “STD test after 24 hours” that reliably rules out every infection. Organisms become detectable at different times, and test performance varies by method and specimen. A baseline test soon after exposure may reveal a pre-existing infection but cannot reliably exclude a new infection acquired that day.
Chlamydia and gonorrhea NAATs may become positive within days, but very early negatives can require repeat testing. For people without symptoms who are testing after a specific exposure, clinicians commonly consider testing around 1–2 weeks depending on circumstances; this is a practical assessment interval, not a universal validated cutoff. Symptoms or a known infected partner may justify earlier evaluation and treatment decisions.
Syphilis blood tests can be negative in early infection. If a new chancre, rash or confirmed partner exposure raises suspicion, a clinician may arrange repeat serology or presumptive treatment when guidelines support it rather than accept a single early negative result.
HIV testing has better-defined method-specific windows. In people not using antiretrovirals, CDC lists approximately 10–33 days for NAT, 18–45 days for a laboratory venous fourth-generation antigen/antibody test, 18–90 days for a rapid finger-stick antigen/antibody test and 23–90 days for antibody tests. PEP and PrEP can alter testing schedules. A reactive screening test requires confirmation.
Hepatitis B and C testing depends on the exposure and selected markers. Hepatitis B surface antigen, antibodies and vaccination status answer different questions; hepatitis C RNA can detect current infection before antibodies develop. A clinician should set the follow-up schedule for a significant blood exposure.
A negative test only applies to the organism, specimen site and time tested. When symptoms persist or exposure occurred within a detection window, the correct response may be a different specimen, repeat test, physical examination or investigation for a non-STI cause.
Symptoms that should prompt clinical assessment
Painful urination, urethral discharge or new genital discharge can indicate urethritis or cervicitis. Gonorrhea and chlamydia are common considerations, but the cause may be different. Appropriate genital NAATs, examination and sometimes urine culture help distinguish them.
Pelvic pain, painful sex, abnormal bleeding or fever can signal pelvic inflammatory disease (PID) or another urgent condition. Delaying treatment may increase the risk of complications. Severe pain, pregnancy, fainting or systemic illness warrants urgent in-person care.
Testicular pain or swelling should not be presumed to be an STI. Epididymitis can be infection-related, but sudden severe unilateral testicular pain may represent torsion, which is an emergency.
Genital sores, ulcers or blisters need early assessment. Herpes, syphilis and noninfectious causes can look similar. Eye symptoms, severe headache, hearing changes or neurological symptoms in someone with possible syphilis require urgent specialist evaluation.
Rectal pain, discharge, bleeding or tenesmus may require rectal examination and testing. The workup can include gonorrhea, chlamydia, herpes, syphilis and non-STI causes. A genital urine panel alone is insufficient.
Sore throat after oral sex does not prove throat gonorrhea. Many sore throats are unrelated to STIs, but site-specific testing can be appropriate when exposure history or a partner diagnosis supports it.
Treatment and medication: what can be prescribed or administered
STI treatment depends on the confirmed or clinically suspected organism, infection site, pregnancy, allergies, drug interactions and antimicrobial resistance. STDtest.clinic’s clinicians can evaluate eligibility for prescriptions, medication supply and suitable home administration within the clinic’s verified DHA/MOHAP and medicine-dispensing permissions. Some infections or complications require referral or treatment in a facility.
Chlamydia is generally treated with antibiotics. CDC’s recommended regimen for many nonpregnant adolescents and adults is doxycycline 100 mg orally twice daily for seven days. Pregnancy changes the recommended approach; azithromycin 1 g orally once is a CDC-recommended regimen in pregnancy. Doxycycline and azithromycin are generic active ingredients; a particular brand’s stock and registration must be checked before promising delivery.
Uncomplicated gonorrhea is usually treated with a ceftriaxone injection. CDC recommends ceftriaxone 500 mg intramuscularly once for people weighing under 150 kg and 1 g once at 150 kg or more. When chlamydia has not been excluded, additional chlamydia treatment may be needed. Drug allergies, suspected resistance, pregnancy and complications change management. Pharyngeal gonorrhea needs a test of cure 7–14 days after treatment.
Syphilis treatment depends on stage and clinical findings. Benzathine penicillin G 2.4 million units intramuscularly once is a standard regimen for primary, secondary and early latent syphilis in adults; late latent syphilis or syphilis of unknown duration usually requires 2.4 million units weekly for three weeks. Neurosyphilis and ocular or otic syphilis require different specialist-directed therapy. Penicillin formulation matters: products are not interchangeable.
Trichomoniasis is treated with a nitroimidazole antibiotic. CDC recommends metronidazole 500 mg orally twice daily for seven days for women, and metronidazole 2 g orally once for men; alternatives and pregnancy considerations require clinical review. Partner management is important.
Genital herpes is managed with antiviral medication, not antibiotics. Acyclovir, valacyclovir and famciclovir can shorten episodes and, when used as suppressive therapy, reduce recurrence and transmission risk. They do not eliminate latent HSV. Regimen choice depends on whether infection is a first episode, recurrence or suppressive treatment, plus renal function and pregnancy.
Genital warts need examination rather than a generic “HPV tablet.” Options may include clinician-applied cryotherapy or selected topical treatments such as imiquimod or podofilox where appropriate. HPV vaccination prevents future infections with vaccine-covered types; it does not cure existing warts.
HIV, hepatitis B and hepatitis C require infection-specific pathways. HIV requires combination antiretroviral therapy under an authorized treatment service. Hepatitis B may require specialist monitoring or antiviral therapy depending on disease activity. Most current hepatitis C infections can be cured with appropriate direct-acting antiviral combinations after evaluation.
Medication names and doses on this page explain guideline-based options; they are not self-prescribing instructions. We confirm the exact drug, formulation, local authorization, availability, prescription, route and administration location before arranging treatment. Patients should not take antibiotics or injections without medical assessment.
At-home STD testing and treatment in Dubai, Abu Dhabi and Sharjah
A qualified healthcare professional can collect suitable STI samples at home or at a hotel when the service is clinically appropriate and authorized for that location. Depending on the requested tests, this may include venous blood collection, urine sample instructions, appropriate self-collected or clinician-collected swabs, and coordination with a laboratory.
A home visit may also include medical examination, prescriptions and administration of selected medicines. Oral medication supply, intramuscular injections or other treatments require the correct diagnosis, licensed prescriber, verified medicine stock, safe administration conditions and an appropriate plan for adverse reactions. We do not promise that every STD can be fully treated during one home visit.
Discreet collection does not mean a laboratory-free diagnosis. Samples are labeled, transported and processed according to the laboratory’s requirements. Confirmatory testing, culture or specialist referral may still be necessary.
Dubai coverage can include premium neighbourhoods subject to confirmed appointment availability. Requested locations may include Arjan, Dubai Marina, JBR, JLT, Palm Jumeirah, Downtown Dubai, Business Bay, DIFC, Jumeirah, Umm Suqeim, Al Barsha, Emirates Hills, Dubai Hills Estate, Arabian Ranches, Jumeirah Golf Estates, Bluewaters Island, City Walk and Dubai Creek Harbour. These are geographic targeting examples, not a guarantee that a visit is currently bookable.
Abu Dhabi and Sharjah appointments depend on emirate-specific authorization and operational coverage. Requests may come from Saadiyat Island, Al Reem Island, Al Maryah Island, Yas Island, Al Raha Beach, Khalifa City, Al Bateen and Corniche areas in Abu Dhabi, or Al Majaz, Al Khan, Al Taawun, Muwaileh and Aljada in Sharjah. Patients elsewhere in the UAE can enquire about an appropriate in-clinic, mobile or referral pathway; availability is confirmed before booking.
A visit in a hotel, serviced apartment or private residence is subject to access and clinical safety. Hotel guests may need to coordinate entry with reception. Mobile services cannot replace emergency facilities, hospital imaging or specialist procedures.
STD test packages: exactly what is included matters
A basic screening package should identify the tests and specimen sites it actually covers. For example, genital chlamydia/gonorrhea NAAT, HIV laboratory antigen/antibody testing and syphilis serology are different investigations with different specimen requirements. They should never be described simply as one universal “STD blood test.”
A comprehensive panel may add tests based on exposure, symptoms or history. Hepatitis B markers, hepatitis C testing, trichomonas NAAT, throat or rectal swabs and lesion HSV PCR are clinically relevant for some patients but not all. Routine asymptomatic HSV serology, HPV blood testing or blanket *M. genitalium* screening should not be sold as essential for everyone.
The parameters must match the actual laboratory order. STDtest.clinic should publish the confirmed test names, sample types, anatomical sites, whether confirmatory tests are included, and any exclusions. [Insert existing approved package parameter lists unchanged once provided; do not invent tests, prices or turnaround times.]
Results are not always same-day. Turnaround varies by laboratory, assay, specimen transport and confirmatory testing. A rapid result may still require follow-up. We confirm the expected timeline for the ordered test before collection.
What happens after your result
A positive result is the start of a treatment plan, not a judgment about when or from whom an infection was acquired. The clinician explains the organism and assay, whether confirmation is needed, treatment options, partner assessment, abstinence advice and follow-up. Results usually cannot prove which partner transmitted an infection or the exact date of acquisition.
Partner management helps prevent reinfection. Depending on the infection, recent partners may need testing or treatment even when they feel well. Patients should follow infection-specific advice about avoiding sex until treatment is complete and partners have been appropriately managed.
A test of cure and retesting for reinfection are different. For uncomplicated chlamydia in nonpregnant patients, routine immediate test of cure is usually unnecessary, and NAATs taken too soon after treatment can remain positive from residual nucleic acid. Retesting around three months is recommended because reinfection is common. Pharyngeal gonorrhea requires a test of cure; syphilis follow-up uses quantitative nontreponemal titres.
A negative result can be reassuring only when it was the correct test at the correct time and site. A clinician may recommend another test after the window period, a different anatomical swab or evaluation for urinary, skin or gynecological conditions.
Persistent symptoms after treatment require reassessment. Possible causes include reinfection, incorrect initial diagnosis, treatment adherence issues, resistance, another STI or a noninfectious condition. Repeating the same antibiotic without evaluation may delay proper care.
HIV PEP, PrEP and other prevention during an STD visit
Possible HIV exposure within the last 72 hours requires urgent PEP assessment. CDC 2025 guidance recommends starting indicated PEP as soon as possible, ideally within 24 hours, for a 28-day course. Initial doses should not be delayed while waiting for routine laboratory results. Patients should seek an emergency-capable service immediately if a routine home appointment cannot meet that timeline.
PrEP is preventive HIV medication for people without HIV who may face ongoing exposure. Common oral combinations include tenofovir disoproxil fumarate 300 mg/emtricitabine 200 mg (TDF/FTC) and tenofovir alafenamide 25 mg/emtricitabine 200 mg (TAF/FTC). They are not interchangeable for every exposure: TAF/FTC has not been studied for prevention through receptive vaginal sex. Baseline HIV testing and appropriate follow-up are required.
PrEP and PEP do not prevent most other STIs. Depending on risk, condoms, hepatitis A/B vaccination, HPV vaccination, routine site-specific testing and partner care remain relevant. DoxyPEP is a separate antibiotic strategy for selected populations, not a universal recommendation.
Privacy, professional standards and patient safety
Sexual-health information is handled through a professional healthcare process, including appropriate consent, identification, recordkeeping and result communication. Confidentiality does not necessarily mean anonymous testing or exemption from statutory reporting. Patients can request the clinic’s approved privacy and disclosure policy before booking.
STDtest.clinic reports that it holds DHA, MOHAP and medicine-sale permissions. The public website should identify the exact licensed legal entity, license numbers, permitted activities and geographic scope after verification. One emirate’s approval does not automatically authorize every mobile service, medicine supply or treatment across the entire UAE.
Emergency symptoms need urgent care, not a scheduled home test. Sudden severe testicular pain, severe pelvic pain, fainting, major bleeding, confusion, eye pain or visual changes, severe allergic reactions, and high fever with systemic illness require immediate in-person assessment.
How STDtest.clinic appointments work
- Describe the concern. Share symptoms, exposure date, relevant anatomical sites, partner information if known, pregnancy possibility, medication allergies and any recent antibiotics or HIV prevention medicines.
- Receive a test and treatment plan. The clinician recommends suitable tests, the correct collection time, whether examination is needed and whether urgent treatment or PEP assessment takes priority.
- Confirm your visit and exact services. The team verifies clinic or mobile availability, service area, licensed clinician, test parameters, expected laboratory timeline, price and whether medicine supply or administration is appropriate.
- Collect specimens or provide eligible care. Samples are collected and processed through the approved laboratory pathway. Where indicated, treatment can be prescribed, dispensed or administered in accordance with the applicable permissions and clinical setting.
- Receive interpretation and follow-up. A positive, negative or inconclusive result is explained with clear next steps, including repeat testing, partner management or referral when required.
Medical information and clinical references
This information supports informed decisions but cannot replace examination, individualized diagnosis or a prescription. Actual medication brands, stock, home administration, laboratory panels, fees, turnaround and UAE-wide visit coverage must be confirmed before a service is advertised as available.